| 1 | Rectal Neoplasms | 51.8% |
| 2 | Adenomatous Polyposis Coli | 50.3% |
| 3 | Cecal Neoplasms | 47.6% |
| 4 | Duodenal Neoplasms | 47.6% |
| 5 | Zollinger-Ellison syndrome | 44.6% |
| 6 | Anus Neoplasms | 40.4% |
| 7 | Stomach Neoplasms | 37.2% |
| 8 | Esophageal Neoplasms | 35.8% |
| 9 | Dysentery | 32.1% |
| 10 | Enteritis | 32.1% |
| 11 | Enterocolitis | 32.1% |
| 12 | Inflammatory Bowel Diseases | 32.1% |
| 13 | Proctocolitis | 31.8% |
| 14 | Appendiceal Neoplasms | 31.5% |
| 15 | Colitis | 29.3% |
| 16 | Duodenitis | 27.5% |
| 17 | Ileitis | 27.5% |
| 18 | Erosive Duodenitis | 27.5% |
| 19 | Mesenteric vascular insufficiency | 25.8% |
| 20 | Intestinal Atresia | 25.6% |
| 21 | Mesenteric Vascular Occlusion | 25.6% |
| 22 | Intestinal Fistula | 25.5% |
| 23 | Enterocutaneous Fistula | 25.5% |
| 24 | Liver neoplasms | 24.9% |
| 25 | Peritoneal Neoplasms | 24.7% |
| 26 | Gastrointestinal Stromal Tumors | 24.6% |
| 27 | Duodenal Obstruction | 24.6% |
| 28 | Esophageal Diseases | 24.2% |
| 29 | Gastroenteritis | 24.2% |
| 30 | Stomach Diseases | 24.2% |
| 31 | Cecal Diseases | 24% |
| 32 | Ileal Diseases | 24% |
| 33 | Intestinal Obstruction | 24% |
| 34 | Intestinal Perforation | 24% |
| 35 | Jejunal Diseases | 24% |
| 36 | Pneumatosis Cystoides Intestinalis | 24% |
| 37 | Rectal Diseases | 24% |
| 38 | Cronkhite-Canada Syndrome | 24% |
| 39 | Intestinal Polyposis | 24% |
| 40 | Duodenogastric Reflux | 23.8% |
| 41 | Peptic Ulcer | 23.8% |
| 42 | Proctitis | 23.8% |
| 43 | Esophagitis | 23% |
| 44 | Gastritis | 23% |
| 45 | Rectal Fistula | 22.8% |
| 46 | Anal Fistula | 22.8% |
| 47 | Pancreatic Neoplasm | 22.4% |
| 48 | Colorectal Neoplasms | 21.8% |
| 49 | Intestinal Diseases, Parasitic | 21.3% |
| 50 | Appendicitis | 20.9% |
| 51 | Gastrointestinal Hemorrhage | 20.9% |
| 52 | Tuberculosis, Gastrointestinal | 20.7% |
| 53 | Colonic Diseases, Functional | 20.7% |
| 54 | Megacolon | 20.7% |
| 55 | Crohn Disease | 19.1% |
| 56 | Enterocolitis, Neutropenic | 19.1% |
| 57 | Necrotizing Enterocolitis | 19.1% |
| 58 | Intestinal Neoplasms | 18.8% |
| 59 | Biliary Tract Diseases | 18.7% |
| 60 | Liver diseases | 18.7% |
| 61 | Pancreatic Diseases | 18.7% |
| 62 | Gastrointestinal Neoplasms | 18.5% |
| 63 | Pouchitis | 18.2% |
| 64 | Colonic Pseudo-Obstruction | 17.9% |
| 65 | Esophageal Atresia | 17.5% |
| 66 | Enterocolitis, Pseudomembranous | 16.7% |
| 67 | pseudomembranous colitis | 16.7% |
| 68 | Dysentery, Bacillary | 16.7% |
| 69 | Colitis, Ischemic | 16.5% |
| 70 | Esophageal and Gastric Varices | 16.1% |
| 71 | Bile Duct Neoplasms | 15.7% |
| 72 | gallbladder neoplasm | 15.7% |
| 73 | Duodenal Ulcer | 15% |
| 74 | Peptic Ulcer Perforation | 15% |
| 75 | Gastric ulcer | 15% |
| 76 | Pancreatic Fistula | 14.7% |
| 77 | Colonic Diseases | 14.6% |
| 78 | Sigmoid Neoplasms | 14.4% |
| 79 | Fecal Incontinence | 14.3% |
| 80 | Fecal Impaction | 14.3% |
| 81 | Intussusception | 14.3% |
| 82 | Ileus | 14.3% |
| 83 | Meconium ileus | 14.3% |
| 84 | Irritable Bowel Syndrome | 13.7% |
| 85 | Neurogenic Bowel | 13.7% |
| 86 | Barrett Esophagus | 13.6% |
| 87 | Esophageal Stenosis | 13.3% |
| 88 | Gastric Dilatation | 13.3% |
| 89 | Gastric outlet obstruction | 13.3% |
| 90 | Hepatocellular Adenoma | 12.5% |
| 91 | Hemorrhoids | 12.5% |
| 92 | Liver Neoplasms, Experimental | 12.3% |
| 93 | Afferent Loop Syndrome | 12.3% |
| 94 | Celiac Disease | 12.3% |
| 95 | Short Bowel Syndrome | 12.3% |
| 96 | Sprue, Tropical | 12.3% |
| 97 | Steatorrhea | 12.3% |
| 98 | Rectocele | 12.3% |
| 99 | Sprue | 12.3% |
| 100 | Rectal Prolapse | 12.3% |
| 101 | Digestive System Neoplasms | 12.2% |
| 102 | Esophageal Perforation | 11.8% |
| 103 | Choledochal Cyst | 11.8% |
| 104 | Deglutition Disorders | 11.6% |
| 105 | Achlorhydria | 11.5% |
| 106 | Gastric Antral Vascular Ectasia | 11.5% |
| 107 | Peptic Ulcer Hemorrhage | 11.4% |
| 108 | Gastroparesis | 11.4% |
| 109 | Peutz-Jeghers Syndrome | 11.2% |
| 110 | Giardiasis | 11% |
| 111 | Pancreatic Cyst | 10.4% |
| 112 | Carcinoma, Pancreatic Ductal | 10.4% |
| 113 | Colonic Neoplasms | 10.1% |
| 114 | Melena | 10.1% |
| 115 | Hematemesis | 10% |
| 116 | Bile Duct Diseases | 9.7% |
| 117 | Cholelithiasis | 9.7% |
| 118 | Chylous Ascites | 9.7% |
| 119 | Fatty Liver | 9.7% |
| 120 | Hepatitis | 9.7% |
| 121 | Portal Hypertension | 9.7% |
| 122 | Intestinal Diseases | 9.7% |
| 123 | Liver Cirrhosis | 9.7% |
| 124 | Pancreatic Insufficiency | 9.7% |
| 125 | Pancreatitis | 9.7% |
| 126 | Pneumoperitoneum | 9.7% |
| 127 | Focal Nodular Hyperplasia | 9.7% |
| 128 | Hepatic Insufficiency | 9.7% |
| 129 | Steatohepatitis | 9.7% |
| 130 | Biliary cirrhosis | 9.6% |
| 131 | Lactose Intolerance | 9.6% |
| 132 | Anal Fissure | 9.5% |
| 133 | Intestinal Pseudo-Obstruction | 9.5% |
| 134 | Superior Mesenteric Artery Syndrome | 9.5% |
| 135 | Anal Ulcer | 9.5% |
| 136 | Cholecystolithiasis | 9.2% |
| 137 | Liver Diseases, Parasitic | 8.6% |
| 138 | Hepatic Veno-Occlusive Disease | 8.4% |
| 139 | Peliosis Hepatis | 8.4% |
| 140 | Hepatopulmonary Syndrome | 8.4% |
| 141 | Anus, Imperforate | 8.3% |
| 142 | Hemoperitoneum | 8.3% |
| 143 | Hepatomegaly | 8.3% |
| 144 | Mesenteric Panniculitis | 8.3% |
| 145 | Panniculitis, Peritoneal | 8.3% |
| 146 | Peritonitis | 8.3% |
| 147 | Peritoneal Fibrosis | 8.3% |
| 148 | Encapsulating Peritoneal Sclerosis | 8.3% |
| 149 | Anorectal Malformations | 8.3% |
| 150 | Biliary Fistula | 8.3% |
| 151 | Gastric Fistula | 8.3% |
| 152 | Hepatic Vein Thrombosis | 8.3% |
| 153 | Liver Abscess | 8.3% |
| 154 | Budd-Chiari Syndrome | 8.3% |
| 155 | Pruritus Ani | 8.2% |
| 156 | Fatty Liver, Alcoholic | 8% |
| 157 | Hepatitis, Alcoholic | 8% |
| 158 | Liver Cirrhosis, Alcoholic | 8% |
| 159 | Cryptosporidiosis | 8% |
| 160 | Esophageal motility disorders | 7.9% |
| 161 | Mallory-Weiss Syndrome | 7.9% |
| 162 | Pyloric Stenosis | 7.9% |
| 163 | Chemical and Drug Induced Liver Injury | 7.4% |
| 164 | Choledocholithiasis | 7.3% |
| 165 | Hepatorenal Syndrome | 7.3% |
| 166 | Abdominal Neoplasms | 6.9% |
| 167 | Head and Neck Neoplasms | 6.9% |
| 168 | Soft Tissue Neoplasms | 6.9% |
| 169 | Thoracic Neoplasms | 6.9% |
| 170 | Diverticulitis | 6.8% |
| 171 | Dumping Syndrome | 6.8% |
| 172 | insulinoma | 6.7% |
| 173 | Cystic Fibrosis | 6.7% |
| 174 | Gastrinoma | 6.7% |
| 175 | Glucagonoma | 6.7% |
| 176 | Porphyrias, Hepatic | 6.5% |
| 177 | Congenital Hyperinsulinism | 6.5% |
| 178 | Liver Abscess, Amebic | 6.5% |
| 179 | Vipoma | 6.2% |
| 180 | Endocrine Gland Neoplasms | 6.1% |
| 181 | Eye Neoplasms | 6.1% |
| 182 | Nervous System Neoplasms | 6.1% |
| 183 | Diverticulum | 6.1% |
| 184 | Diverticulosis | 6.1% |
| 185 | Bone neoplasms | 6% |
| 186 | Skin Neoplasms | 6% |
| 187 | Hematologic Neoplasms | 6% |
| 188 | Splenic Neoplasms | 5.9% |
| 189 | Pancreatic Pseudocyst | 5.6% |
| 190 | Cholangitis | 5.3% |
| 191 | Cholecystitis | 5.3% |
| 192 | Cholestasis | 5.3% |
| 193 | Common Bile Duct Diseases | 5.3% |
| 194 | Hepatitis, Chronic | 5.3% |
| 195 | Liver Failure | 5.3% |
| 196 | Pancreatitis, Chronic | 5.3% |
| 197 | Non-alcoholic Fatty Liver Disease | 5.3% |
| 198 | Chronic active hepatitis | 5.3% |
| 199 | Esophageal Achalasia | 5.3% |
| 200 | Multiple Endocrine Neoplasia | 5.1% |
| 201 | Parathyroid Neoplasms | 4.9% |
| 202 | Thyroid Neoplasm | 4.9% |
| 203 | Thyroid carcinoma | 4.9% |
| 204 | Hepatitis, Animal | 4.7% |
| 205 | Hepatitis, Viral, Human | 4.7% |
| 206 | Gastrointestinal Diseases | 4.7% |
| 207 | Liver Cirrhosis, Experimental | 4.6% |
| 208 | Pancreatitis, Alcoholic | 4.6% |
| 209 | Hamartoma | 4.5% |
| 210 | Neoplasms, Hormone-Dependent | 4.5% |
| 211 | Neoplasms, Multiple Primary | 4.5% |
| 212 | Paraneoplastic Syndromes | 4.5% |
| 213 | Precancerous Conditions | 4.5% |
| 214 | Neoplasms, Second Primary | 4.5% |
| 215 | Paraneoplastic Encephalomyelitis | 4.5% |
| 216 | Mammary Neoplasms, Experimental | 4.5% |
| 217 | Fascioliasis | 4.1% |
| 218 | Echinococcosis, Hepatic | 4.1% |
| 219 | Chemical and Drug Induced Liver Injury, Chronic | 4% |
| 220 | Reye Syndrome | 4% |
| 221 | Cyst | 3.9% |
| 222 | Neoplastic Processes | 3.9% |
| 223 | Neoplastic Syndromes, Hereditary | 3.9% |
| 224 | Pregnancy Complications, Neoplastic | 3.9% |
| 225 | Neoplasms, Experimental | 3.9% |
| 226 | Zellweger Syndrome | 3.9% |
| 227 | Tracheal Neoplasms | 3.8% |
| 228 | Acanthoma | 3.7% |
| 229 | Hepatolenticular Degeneration | 3.6% |
| 230 | Retroperitoneal Neoplasms | 3.6% |
| 231 | Nesidioblastosis | 3.6% |
| 232 | Variegate Porphyria | 3.6% |
| 233 | Acute intermittent porphyria | 3.6% |
| 234 | Porphyria Cutanea Tarda | 3.6% |
| 235 | Hepatitis B, Chronic | 3.6% |
| 236 | Hepatitis C, Chronic | 3.6% |
| 237 | Laryngopharyngeal Reflux | 3.4% |
| 238 | Neoplasms, Radiation-Induced | 3.4% |
| 239 | Cholestasis, Extrahepatic | 3.2% |
| 240 | Biliary Dyskinesia | 3.2% |
| 241 | Cholangitis, Sclerosing | 3.2% |
| 242 | Liver Failure, Acute | 3.2% |
| 243 | Acalculous Cholecystitis | 3.2% |
| 244 | End Stage Liver Disease | 3.2% |
| 245 | Mouth Neoplasms | 3.1% |
| 246 | Central Nervous System Neoplasms | 3.1% |
| 247 | Vascular Neoplasms | 3.1% |
| 248 | Thymus Neoplasms | 3.1% |
| 249 | Testicular Neoplasms | 3.1% |
| 250 | Carcinoma, Lobular | 3.1% |
| 251 | Genital Neoplasms, Female | 3.1% |
| 252 | Breast Neoplasms, Male | 3.1% |
| 253 | Triple Negative Breast Neoplasms | 3.1% |
| 254 | Tuberous Sclerosis | 3% |
| 255 | CREST Syndrome | 2.9% |
| 256 | Adrenal Gland Neoplasms | 2.8% |
| 257 | Genital Neoplasms, Male | 2.8% |
| 258 | Uveal Neoplasms | 2.8% |
| 259 | Autoimmune hepatitis | 2.8% |
| 260 | Urologic Neoplasms | 2.7% |
| 261 | Sebaceous Gland Neoplasms | 2.7% |
| 262 | Spinal Neoplasms | 2.7% |
| 263 | Bone Marrow Neoplasms | 2.7% |
| 264 | Thyroid Nodule | 2.7% |
| 265 | Multiple Endocrine Neoplasia Type 1 | 2.7% |
| 266 | Trophoblastic Neoplasms | 2.6% |
| 267 | Leukemia, Experimental | 2.6% |
| 268 | Carcinoma, Ehrlich Tumor | 2.5% |
| 269 | Dermoid Cyst | 2.5% |
| 270 | Carcinoma, Lewis Lung | 2.5% |
| 271 | Carcinoma 256, Walker | 2.5% |
| 272 | Hepatitis, Viral, Animal | 2.5% |
| 273 | Hepatitis E | 2.5% |
| 274 | Hepatitis B | 2.4% |
| 275 | Hepatitis C | 2.4% |
| 276 | Hepatitis A | 2.4% |
| 277 | Thymoma | 2.4% |
| 278 | Meningioma | 2.4% |
| 279 | Hepatic Encephalopathy | 2.4% |
| 280 | Leukemia, Radiation-Induced | 2.4% |
| 281 | Erythroplasia | 2.3% |
| 282 | Follicular cyst | 2.3% |
| 283 | leukemia | 2.3% |
| 284 | Mucocele | 2.3% |
| 285 | Neoplasms, Germ Cell and Embryonal | 2.3% |
| 286 | Neoplasms, Glandular and Epithelial | 2.3% |
| 287 | Pilonidal Cyst | 2.3% |
| 288 | Thyroglossal Cyst | 2.3% |
| 289 | Synovial Cyst | 2.3% |
| 290 | Germ Cell Cancer | 2.3% |
| 291 | Aberrant Crypt Foci | 2.3% |
| 292 | Sarcoma, Experimental | 2.2% |
| 293 | ovarian neoplasm | 2.2% |
| 294 | Nephroblastoma | 2.2% |
| 295 | Leukoplakia, Oral | 2.2% |
| 296 | Paraneoplastic Cerebellar Degeneration | 2.1% |
| 297 | Massive Hepatic Necrosis | 2.1% |
| 298 | Emphysematous Cholecystitis | 2.1% |
| 299 | Sphincter of Oddi Dysfunction | 2.1% |
| 300 | Melanoma, Experimental | 2.1% |
| 301 | Nose Neoplasms | 2.1% |
| 302 | Neuroectodermal Tumors | 2.1% |
| 303 | Leukoplakia | 2% |
| 304 | Lymphocele | 2% |
| 305 | Breast Cyst | 2% |
| 306 | Histiocytic Disorders, Malignant | 2% |
| 307 | Actinic keratosis | 2% |
| 308 | Mediastinal Cyst | 2% |
| 309 | Neoplasm Invasiveness | 2% |
| 310 | Neoplasm Metastasis | 2% |
| 311 | Neoplasm Recurrence, Local | 2% |
| 312 | Parovarian Cyst | 2% |
| 313 | Pericardial Cyst | 2% |
| 314 | Thymic Cyst | 2% |
| 315 | Carcinogenesis | 2% |
| 316 | Myxoid cyst | 2% |
| 317 | Metastasis | 2% |
| 318 | Pituitary Adenoma | 2% |
| 319 | Pituitary Neoplasms | 2% |
| 320 | Limbic Encephalitis | 1.9% |
| 321 | Neoplasms, Neuroepithelial | 1.9% |
| 322 | Gliomatosis cerebri | 1.9% |
| 323 | Lambert-Eaton Myasthenic Syndrome | 1.8% |
| 324 | Lymphomatoid Granulomatosis | 1.8% |
| 325 | Palatal Neoplasms | 1.8% |
| 326 | Retinoblastoma | 1.8% |
| 327 | Lymphoma | 1.7% |
| 328 | Acoustic Neuroma | 1.7% |
| 329 | Corpus Luteum Cyst | 1.7% |
| 330 | Ovarian Cysts | 1.7% |
| 331 | Meningeal Neoplasms | 1.7% |
| 332 | Opsoclonus-Myoclonus Syndrome | 1.6% |
| 333 | Composite Lymphoma | 1.6% |
| 334 | Prolactinoma | 1.6% |
| 335 | Growth Hormone-Secreting Pituitary Adenoma | 1.6% |
| 336 | Carcinosarcoma | 1.6% |
| 337 | Hemangiosarcoma | 1.6% |
| 338 | Leukemia L1210 | 1.6% |
| 339 | Leukemia P388 | 1.6% |
| 340 | lymphangiosarcoma | 1.6% |
| 341 | Ear Neoplasms | 1.5% |
| 342 | Eyelid Neoplasms | 1.5% |
| 343 | Lung Neoplasms | 1.5% |
| 344 | Pleural Neoplasms | 1.5% |
| 345 | Choriocarcinoma | 1.5% |
| 346 | Brain Neoplasms | 1.5% |
| 347 | Salivary Gland Neoplasms | 1.5% |
| 348 | Spinal Cord Neoplasms | 1.5% |
| 349 | Tongue Neoplasms | 1.5% |
| 350 | Basal Cell Nevus Syndrome | 1.5% |
| 351 | melanoma | 1.5% |
| 352 | Uterine Neoplasms | 1.5% |
| 353 | Vaginal Neoplasms | 1.5% |
| 354 | Vulvar Neoplasms | 1.5% |
| 355 | Uterine Cancer | 1.5% |
| 356 | Myelitis, Transverse | 1.5% |
| 357 | Fallopian Tube Neoplasms | 1.5% |
| 358 | granulosa cell tumor | 1.5% |
| 359 | Carcinoma, Ovarian Epithelial | 1.5% |
| 360 | Leukemia, Plasma Cell | 1.4% |
| 361 | Pharyngeal Neoplasms | 1.4% |
| 362 | Sarcoma 180 | 1.4% |
| 363 | Central Nervous System Cysts | 1.4% |
| 364 | Penile Neoplasms | 1.3% |
| 365 | Prostatic Neoplasms | 1.3% |
| 366 | Polycythemia Vera | 1.3% |
| 367 | Mesoblastic Nephroma | 1.3% |
| 368 | Laryngeal neoplasm | 1.2% |
| 369 | Bladder Neoplasm | 1.2% |
| 370 | Kidney Neoplasm | 1.2% |
| 371 | Ureteral Neoplasms | 1.2% |
| 372 | Urethral Neoplasms | 1.2% |
| 373 | Adenoma | 1.2% |
| 374 | Ameloblastoma | 1.2% |
| 375 | Angiokeratoma | 1.2% |
| 376 | Carcinoma | 1.2% |
| 377 | Chordoma | 1.2% |
| 378 | Hemangioma | 1.2% |
| 379 | hemangiopericytoma | 1.2% |
| 380 | Lymphangioma | 1.2% |
| 381 | Mesenchymoma | 1.2% |
| 382 | Nevus | 1.2% |
| 383 | Teratoma | 1.2% |
| 384 | Hepatoblastoma | 1.2% |
| 385 | Mixed Tumor, Mullerian | 1.2% |
| 386 | Germinoma | 1.2% |
| 387 | Teratocarcinoma | 1.2% |
| 388 | Angiofibroma | 1.2% |
| 389 | Sarcoma | 1.2% |
| 390 | Epithelioma | 1.2% |
| 391 | Rift Valley Fever | 1.2% |
| 392 | Leydig Cell Tumor | 1.2% |
| 393 | Optic Nerve Glioma | 1.2% |
| 394 | Basal cell carcinoma | 1.1% |
| 395 | Carcinoma, Papillary | 1.1% |
| 396 | Squamous cell carcinoma | 1.1% |
| 397 | Chondrosarcoma | 1.1% |
| 398 | Craniopharyngioma | 1.1% |
| 399 | Cystadenoma | 1.1% |
| 400 | leiomyosarcoma | 1.1% |
| 401 | liposarcoma | 1.1% |
| 402 | Mesothelioma | 1.1% |
| 403 | synovial sarcoma | 1.1% |
| 404 | Neuroectodermal Tumor, Melanotic | 1.1% |
| 405 | Angiomyolipoma | 1.1% |
| 406 | Clear Cell Sarcoma of Soft Tissue | 1.1% |
| 407 | Alveolar Soft Part Sarcoma | 1.1% |
| 408 | Neuroendocrine Tumors | 1.1% |
| 409 | Sarcoma, Myeloid | 1.1% |
| 410 | Carcinoma, Basal Cell | 1.1% |
| 411 | Adenoma, Acidophil | 1.1% |
| 412 | Ganglioneuroma | 1.1% |
| 413 | Glioma | 1.1% |
| 414 | Malignant Glioma | 1.1% |
| 415 | Xeroderma Pigmentosum | 1.1% |
| 416 | Endometrial Stromal Sarcoma | 1.1% |
| 417 | Plasmacytoma | 1% |
| 418 | Malignant histiocytosis | 1% |
| 419 | Lymphatic Metastasis | 1% |
| 420 | Neoplasms, Unknown Primary | 1% |
| 421 | Leukemic Infiltration | 1% |
| 422 | Histiocytic sarcoma | 1% |
| 423 | Neoplasm Micrometastasis | 1% |
| 424 | Meningeal Carcinomatosis | 1% |
| 425 | Medulloblastoma | 1% |
| 426 | Adrenocortical carcinoma | 1% |
| 427 | Denys-Drash Syndrome | 0.9% |
| 428 | Bronchial Neoplasms | 0.9% |
| 429 | Cystadenocarcinoma | 0.9% |
| 430 | Fibrosarcoma | 0.9% |
| 431 | Osteosarcoma | 0.9% |
| 432 | Mucoepidermoid Carcinoma | 0.9% |
| 433 | Multiple Pulmonary Nodules | 0.9% |
| 434 | Hodgkin Disease | 0.9% |
| 435 | Lymphoma, Non-Hodgkin | 0.9% |
| 436 | Polycystic Ovary Syndrome | 0.9% |
| 437 | Supratentorial Neoplasms | 0.9% |
| 438 | Carcinoid Tumor | 0.9% |
| 439 | Endometrial Neoplasms | 0.9% |
| 440 | Neurilemmoma | 0.9% |
| 441 | Hutchinson's Melanotic Freckle | 0.9% |
| 442 | Melanoma, Amelanotic | 0.9% |
| 443 | Lymphangioleiomyomatosis | 0.9% |
| 444 | Renal Cell Carcinoma | 0.9% |
| 445 | Papillary Renal Cell Carcinoma | 0.9% |
| 446 | Primary amyloidosis | 0.8% |
| 447 | Hypopharyngeal Neoplasms | 0.8% |
| 448 | Pleural Effusion, Malignant | 0.8% |
| 449 | Hypopharyngeal Cancer | 0.8% |
| 450 | Parotid Neoplasms | 0.8% |
| 451 | Prostatic Neoplasms, Castration-Resistant | 0.8% |
| 452 | Nelson Syndrome | 0.8% |
| 453 | Hydatidiform Mole | 0.8% |
| 454 | Adenofibroma | 0.8% |
| 455 | Fibroadenoma | 0.8% |
| 456 | Malignant Fibrous Histiocytoma | 0.8% |
| 457 | Nasopharyngeal carcinoma | 0.7% |
| 458 | Astrocytoma | 0.7% |
| 459 | Ependymoma | 0.7% |
| 460 | oligodendroglioma | 0.7% |
| 461 | Ganglioglioma | 0.7% |
| 462 | gliosarcoma | 0.7% |
| 463 | Anaplastic astrocytoma | 0.7% |
| 464 | Anaplastic Oligodendroglioma | 0.7% |
| 465 | Bowen's Disease | 0.7% |
| 466 | Paraganglioma | 0.7% |
| 467 | Rhabdomyosarcoma | 0.7% |
| 468 | Giant Cell Tumor of Bone | 0.7% |
| 469 | Nasopharyngeal Neoplasms | 0.7% |
| 470 | Adenocarcinoma | 0.7% |
| 471 | Carcinoma in Situ | 0.7% |
| 472 | Carcinoma, Transitional Cell | 0.7% |
| 473 | Phyllodes Tumor | 0.7% |
| 474 | Dysgerminoma | 0.7% |
| 475 | Hemangioendothelioma | 0.7% |
| 476 | Lipoma | 0.7% |
| 477 | Waldenstrom Macroglobulinemia | 0.7% |
| 478 | Multiple Myeloma | 0.7% |
| 479 | Myoma | 0.7% |
| 480 | Myxoma | 0.7% |
| 481 | Neuroma | 0.7% |
| 482 | Papilloma | 0.7% |
| 483 | Pseudomyxoma Peritonei | 0.7% |
| 484 | Seminoma | 0.7% |
| 485 | Papillomatosis | 0.7% |
| 486 | Angiolipoma | 0.7% |
| 487 | Myelolipoma | 0.7% |
| 488 | Neoplasms, Bone Tissue | 0.7% |
| 489 | Neoplasms, Fibrous Tissue | 0.7% |
| 490 | Smooth Muscle Tumor | 0.7% |
| 491 | Adenomatosis, Pulmonary | 0.7% |
| 492 | Adenomatous Polyps | 0.7% |
| 493 | Carcinoma, Large Cell | 0.7% |
| 494 | Carcinoma, Small Cell | 0.7% |
| 495 | Desmoplastic Small Round Cell Tumor | 0.7% |
| 496 | Chondroma | 0.7% |
| 497 | Enchondroma | 0.7% |
| 498 | Carcinoma, Endometrioid | 0.6% |
| 499 | Neurofibrosarcoma | 0.6% |
| 500 | Paranasal Sinus Neoplasms | 0.6% |
| 501 | Brain Stem Neoplasms | 0.6% |
| 502 | Malignant Carcinoid Syndrome | 0.6% |
| 503 | Leukemia, Myelomonocytic, Chronic | 0.6% |
| 504 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 0.6% |
| 505 | Dermatofibrosarcoma | 0.6% |
| 506 | Dermatofibrosarcoma Protuberans | 0.6% |
| 507 | Tonsillar Neoplasms | 0.5% |
| 508 | Cerebellar Neoplasms | 0.5% |
| 509 | Mastocytosis | 0.5% |
| 510 | Sturge-Weber Syndrome | 0.5% |
| 511 | Cell Transformation, Viral | 0.5% |
| 512 | Hemangioma, Cavernous | 0.5% |
| 513 | Leukemia, T-Cell | 0.5% |
| 514 | Leukemia, B-Cell | 0.5% |
| 515 | neurofibroma | 0.5% |
| 516 | Lymphoma, Follicular | 0.5% |
| 517 | T-Cell Lymphoma | 0.5% |
| 518 | Mantle cell lymphoma | 0.5% |
| 519 | Glioblastoma | 0.5% |
| 520 | Neuroblastoma | 0.5% |
| 521 | Glioblastoma Multiforme | 0.5% |
| 522 | Pheochromocytoma | 0.5% |
| 523 | Alveolar rhabdomyosarcoma | 0.5% |
| 524 | Choroid Plexus Papilloma | 0.4% |
| 525 | Carcinoid Heart Disease | 0.4% |
| 526 | Maxillary Sinus Neoplasms | 0.4% |
| 527 | Adenoid Cystic Carcinoma | 0.4% |
| 528 | fibroma | 0.4% |
| 529 | Fibromatosis | 0.4% |
| 530 | Osteoblastoma | 0.4% |
| 531 | Osteoma | 0.4% |
| 532 | Rhabdomyoma | 0.4% |
| 533 | Chondromatosis | 0.4% |
| 534 | Adenocarcinoma, Clear Cell | 0.4% |
| 535 | Cholangiocarcinoma | 0.4% |
| 536 | Cervical Intraepithelial Neoplasia | 0.4% |
| 537 | Hemangioblastoma | 0.4% |
| 538 | Lymphoma, Extranodal NK-T-Cell | 0.4% |
| 539 | Ganglioneuroblastoma | 0.4% |
| 540 | Mastocytoma | 0.3% |
| 541 | Mastocytosis, Systemic | 0.3% |
| 542 | Leukemia, Myeloid, Chronic-Phase | 0.3% |
| 543 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.3% |
| 544 | Leukemia, Large Granular Lymphocytic | 0.3% |
| 545 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.3% |
| 546 | Lymphoma, T-Cell, Cutaneous | 0.3% |
| 547 | Lymphoma, AIDS-Related | 0.3% |
| 548 | Enteropathy-Associated T-Cell Lymphoma | 0.3% |
| 549 | Primary Effusion Lymphoma | 0.3% |
| 550 | Fibromatosis, Aggressive | 0.3% |
| 551 | Fibromatosis, Abdominal | 0.3% |
| 552 | Klatskin Tumor | 0.3% |
| 553 | Burkitt Lymphoma | 0.2% |
| 554 | Dupuytren Contracture | 0.2% |
| 555 | Urticaria Pigmentosa | 0.2% |
| 556 | Mycosis Fungoides | 0.2% |
| 557 | Lymphomatoid Papulosis | 0.2% |
| 558 | Plasmablastic lymphoma | 0.2% |
| 559 | Sezary Syndrome | 0.2% |
| 560 | Radicular Cyst | 0.2% |
